Barclays Raises Hims & Hers Target After Novo Deal Clears
Barclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
A concise guide on selecting core crypto assets for beginners who plan to buy and hold for the long term.
28,656 articlesBarclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
The YieldMax MSFT Option Income Strategy ETF (MSFO) continues to lure income-seeking investors with weekly payouts, b...
Regional markets back demand remains resilient as rate pressure builds, with Texas leading loan activity and Californ...
SLV has surged about 132% over the past year as inflation fears persist. But the 0.50% annual fee and a 28% tax on co...
Canaccord Genuity raised its price target on C3.ai to $8 from $7 after Tom Siebel returned as CEO, amid preliminary Q...
Copper prices surge to multi-year highs as supply tightness persists. Four copper miners under $30 are showing signs ...
Markets edged higher Monday evening as news of a potential Hormuz reopening deal spread, easing supply concerns. At t...
A bold forecast from Google Gemini AI points to a dramatic Micron price move by year-end 2026. Analysts say the model...
Dream Finders’ bid for Beazer has evolved into a live governance case, testing board discretion against shareholder r...
Hillary Clinton testifies in New York as part of a House probe into Jeffrey Epstein, with Bill Clinton expected to fo...
Three years after the last profile, a seasoned investor shares how steady saving, smart investing, and deliberate spe...
Oracle has big cloud plans, aiming for massive revenue growth by 2030. A pivotal $110 billion catalyst could make tha...